Hematopoietic stem cell transplantation for AIDS-related malignancies.

Current Opinion in Oncology
Amrita Krishnan, Stephen J Forman

Abstract

AIDS-related malignancies are an ongoing cause of mortality in individuals with HIV infection. In the HIV-negative setting, high-dose chemotherapy or stem cell transplantation is an option for patients with hematologic malignancies. Prior to the advent of effective HIV therapy, stem cell transplantation was not feasible for HIV-positive patients. The purpose of this article is to explore the transplant options for HIV-positive patients after widespread use of highly active antiretroviral therapy. Early autologous stem cell transplantation has studies had high relapse rates but they demonstrated that mobilization and engraftment of autologous stem cells were possible in AIDS patients. Recently, in less advanced AIDS lymphoma, autologous stem cell transplantation has resulted in low transplant-related mortality and durable remissions. In addition, case-control studies of HIV-positive versus HIV-negative lymphoma patients undergoing autologous stem cell transplantation have shown similar transplant-related mortality and overall survival. The feasibility of allogeneic stem cell transplantation in HIV-infected individuals is less tested. There are challenges of drug interactions between highly active antiretroviral therapy and immun...Continue Reading

References

Dec 1, 1996·Bone Marrow Transplantation·J GabarreJ L Binet
Jul 26, 2002·The New England Journal of Medicine·Scott D HalpernArthur L Caplan
Aug 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·François BouéDominique Costagliola
Dec 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Thomas R SpitzerDavid T Scadden
Jun 25, 2008·Blood·Werner Held
Feb 14, 2009·The New England Journal of Medicine·Gero HütterEckhard Thiel
Mar 25, 2009·Blood·José L Díez-MartínUNKNOWN European Group for Blood and Marrow Transplantation Lymphoma Working Party
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pascual BalsalobreAnna Sureda

❮ Previous
Next ❯

Citations

Dec 3, 2014·The Lancet Oncology·Daniela C Stefan
Oct 24, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Lawrence D PetzRobert Chow
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christine DurandStephen Forman
Mar 12, 2011·Blood·Raphaelle Parker, Irini Sereti
Jun 11, 2020·Current HIV/AIDS Reports·Cecilia A PratorTimothy J Henrich

❮ Previous
Next ❯

Related Concepts

Related Feeds

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.